Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Angela Guo is a high school student from Hong Kong currently studying at Phillips Academy Andover. She has spent the past year researching the impacts of nuclear testing on the Marshall Islands and recently published her first book, “At the Tide’s Mercy: Voices from the Marshallese Exodus”.
Sign up for our newsletter to get the latest on nuclear and biological threats.
The development of SynthID Bio by a major frontier AI lab is an important reminder that responsible development and cutting-edge progress are not mutually exclusive.
The Trump and Xi summit today may offer an opportunity to begin filling the leadership vacuum on AI advances, especially with respect to bioweapons. If the reports from AI companies are correct, it’s imperative that Presidents Trump and Xi start this work now.
As NTI celebrates 25 years of impact, we remain committed to reducing the risks of accidental release and deliberate misuse of life science innovations, strengthening global biosecurity, and guiding efforts to govern emerging technologies.
The policy challenge ahead is ensuring that safeguards, governance frameworks, and security practices continue to responsibly scale alongside the technology. If they do, society can capture AI's enormous benefits while keeping emerging risks firmly under control.
As scientific and technological advances accelerate, the Biological Weapons Convention (BWC) faces a defining test. The BWC’s future depends on whether the world can match the pace of biological innovation with equally ambitious efforts to prevent catastrophe.
As protein design tools and other biological AI models become more capable of designing novel biological components and systems, the mechanisms to prevent misuse have not kept pace.
The AHS Index is an objective, evidence-based tool that helps countries and organizations set priorities and identify where investments can have the greatest impact. As health threats become more complex and interconnected, maintaining momentum will require sustained investment, stronger partnerships, and continued political commitment.
Multisectoral collaboration is a fundamental requirement for stronger health security.
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
The convergence of artificial intelligence and the life sciences continues to accelerate. The AIxBio Horizon Scan: Spring 2026 shows that while individual advances may seem incremental, their combined trajectory is significant. Progress is outpacing governance frameworks.
Senior Director, Communications
Director, Communications
Sign up for regular updates on innovative, real-world solutions to existential threats.
